IRIS Institutional Research Information System - OPENBS Open Archive UniBS

RUSSO, ISABELLA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 3.415
EU - Europa 3.030
AS - Asia 2.185
SA - Sud America 387
AF - Africa 61
OC - Oceania 8
Continente sconosciuto - Info sul continente non disponibili 4
Totale 9.090
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 3.346
PL - Polonia 1.568
CN - Cina 777
SG - Singapore 708
BR - Brasile 329
UA - Ucraina 317
IT - Italia 221
HK - Hong Kong 213
VN - Vietnam 207
FR - Francia 197
DE - Germania 191
FI - Finlandia 189
GB - Regno Unito 130
RU - Federazione Russa 75
TR - Turchia 58
IE - Irlanda 54
BD - Bangladesh 46
CA - Canada 41
IN - India 40
ID - Indonesia 27
AR - Argentina 20
ZA - Sudafrica 20
JP - Giappone 17
BE - Belgio 16
KR - Corea 16
MX - Messico 15
NL - Olanda 14
EC - Ecuador 13
ES - Italia 13
NG - Nigeria 10
PK - Pakistan 10
IQ - Iraq 9
AT - Austria 8
AU - Australia 8
MA - Marocco 8
CO - Colombia 7
OM - Oman 7
SE - Svezia 7
CZ - Repubblica Ceca 6
IR - Iran 6
JO - Giordania 6
KE - Kenya 6
PY - Paraguay 6
IL - Israele 5
TN - Tunisia 5
BG - Bulgaria 4
EG - Egitto 4
ET - Etiopia 4
EU - Europa 4
PH - Filippine 4
PS - Palestinian Territory 4
SA - Arabia Saudita 4
VE - Venezuela 4
CL - Cile 3
GR - Grecia 3
KZ - Kazakistan 3
LT - Lituania 3
NP - Nepal 3
PE - Perù 3
UZ - Uzbekistan 3
AE - Emirati Arabi Uniti 2
AL - Albania 2
BB - Barbados 2
BY - Bielorussia 2
CH - Svizzera 2
CR - Costa Rica 2
DZ - Algeria 2
KG - Kirghizistan 2
SV - El Salvador 2
TH - Thailandia 2
TT - Trinidad e Tobago 2
UY - Uruguay 2
AM - Armenia 1
AO - Angola 1
CY - Cipro 1
DK - Danimarca 1
DO - Repubblica Dominicana 1
GT - Guatemala 1
HN - Honduras 1
HU - Ungheria 1
KH - Cambogia 1
LB - Libano 1
LV - Lettonia 1
MD - Moldavia 1
MK - Macedonia 1
MY - Malesia 1
NI - Nicaragua 1
PA - Panama 1
RS - Serbia 1
SC - Seychelles 1
SI - Slovenia 1
SK - Slovacchia (Repubblica Slovacca) 1
TW - Taiwan 1
Totale 9.090
Salva come PNG Salva come JPEG
Città #
Warsaw 1.567
Singapore 400
Ashburn 330
Fairfield 308
Jacksonville 242
Hong Kong 212
Woodbridge 204
Beijing 167
San Jose 164
Helsinki 147
Seattle 139
The Dalles 131
Houston 130
Cambridge 127
Chandler 106
Princeton 104
New York 102
Wilmington 100
Ann Arbor 88
Nanjing 87
Brescia 80
Lauterbourg 63
Los Angeles 61
Council Bluffs 58
Ho Chi Minh City 55
Dong Ket 54
Dublin 54
Istanbul 49
Hanoi 44
Dearborn 40
Moscow 39
Dallas 38
Buffalo 36
Munich 34
Changsha 32
Milan 32
São Paulo 29
Nanchang 28
Chicago 25
Des Moines 25
Shanghai 24
Orem 23
Hebei 22
Jakarta 22
Redondo Beach 22
Shenyang 22
Phoenix 20
San Francisco 20
Tianjin 20
Frankfurt am Main 18
Jiaxing 17
Jinan 17
Tokyo 17
Brussels 16
London 16
Turku 16
Guangzhou 15
Lappeenranta 15
Santa Clara 15
Johannesburg 14
Toronto 14
Zhengzhou 14
San Diego 12
Hangzhou 11
Kunming 11
Poplar 11
Rio de Janeiro 11
Curitiba 10
Montreal 10
Nuremberg 10
Abuja 9
Atlanta 9
Brasília 9
Brooklyn 9
Denver 9
Burlington 8
Chennai 8
Taizhou 8
Amsterdam 7
Belo Horizonte 7
Dhaka 7
Lancaster 7
Ningbo 7
Salt Lake City 7
Taiyuan 7
Baltimore 6
Basingstoke 6
Boston 6
Fuzhou 6
Goiânia 6
Hefei 6
Mexico City 6
Nairobi 6
Stockholm 6
Turin 6
Amman 5
Augusta 5
Falkenstein 5
Guayaquil 5
Haikou 5
Totale 6.419
Salva come PNG Salva come JPEG
Nome #
Effects of neuroinflammation on the regenerative capacity of brain stem cells 329
3,6'-Dithiothalidomide, a new TNF-α synthesis inhibitor, attenuates the effect of Aβ1-42 intracerebroventricular injection on hippocampal neurogenesis and memory deficit 326
Cyclooxygenase-1 is involved in the inhibition of hippocampal neurogenesis after lipopolysaccharide-induced neuroinflammation 277
LRRK2 kinase activity regulates synaptic vesicle trafficking and neurotransmitter release through modulation of LRRK2 macro-molecular complex 264
AMPA receptor regulation at the mRNA and protein level in rat primary cortical cultures 260
Molecular insights and functional implication of LRRK2 dimerization 253
Genetic and pharmacological evidence that G2019S LRRK2 confers a hyperkinetic phenotype, resistant to motor decline associated with aging 244
Cross-talk between LRRK2 and PKA: Implication for Parkinson's disease? 239
Age-dependent dopamine transporter dysfunction and Serine129 phospho-α-synuclein overload in G2019S LRRK2 mice 234
LRRK2 phosphorylates pre-synaptic N-ethylmaleimide sensitive fusion (NSF) protein enhancing its ATPase activity and SNARE complex disassembling rate 231
Leucine-rich repeat kinase 2 interacts with p21-activated kinase 6 to control neurite complexity in mammalian brain 225
Leucine-rich repeat kinase 2 positively regulates inflammation and down-regulates NF-κB p50 signaling in cultured microglia cells 222
LRRK2 and neuroinflammation: Partners in crime in Parkinson's disease? 213
ADAR therapy: a breakthrough against genetic disorders 209
Exosomes-associated neurodegeneration and progression of Parkinson's disease 201
AMPA receptor regulation at the mRNA and protein level in rat primary cortical cultures 199
AMPA RECEPTOR PROPERTIES ARE MODULATED IN THE EARLY STAGES FOLLOWING PILOCARPINE-INDUCED STATUS EPILEPTICUS 176
Leucine-Rich Repeat Kinase-2 Controls the Differentiation and Maturation of Oligodendrocytes in Mice and Zebrafish 149
α-Synuclein and Glia in Parkinson’s Disease: A Beneficial or a Detrimental Duet for the Endo-Lysosomal System? 141
The LRRK2 variant E193K prevents mitochondrial fission upon MPP+ treatment by altering LRRK2 binding to DRP1 138
Activation of neuronal differentiation in vivo and in vitro by means of synthetic peptide 135
Modulation of dendritic AMPA receptor mRNA trafficking by RNA splicing and editing 135
Modulation of dendritic AMPA receptor mRNA trafficking by RNA splicing and editing 135
Modulation of dendritic AMPA receptor mRNA trafficking by RNA splicing and editing 131
The role of LRRK2 on PKA-NFκB pathway in microglia cells: implications for Parkinson's disease 130
Exploring LRRK2-dependent clearance of α-synuclein pffs in glial cells via clusterin 129
EXPLORING LRRK2 BIOLOGY IN GLIAL CELLS: IMPLICATION FOR PARKINSON’S DISEASE 128
Extracellular clusterin limits the uptake of α-synuclein fibrils by murine and human astrocytes 128
Parkinson’s disease LRRK2 modulates microglia physiology in health and disease 126
Transcriptome analysis of LRRK2 knock-out microglia cells reveals alterations of inflammatory- and oxidative stress-related pathways upon treatment with α-synuclein fibrils. 125
LRRK2 phosphorylation on synapsin I regulates glutamate release at presynaptic sites. 121
Tumor necrosis factor-α synthesis inhibitor 3,6'-dithiothalidomide attenuates markers of inflammation, Alzheimer pathology and behavioral deficits in animal models of neuroinflammation and Alzheimer's disease 114
Leucine-rich repeat kinase-2 controls protein kinase A activation state through phosphodiesterase 4 113
In vitro and in vivo analysis of dendritic AMPA receptor mRNAs trafficking 111
3,6'-Dithiothalidomide, a TNF-α inhibitor, attenuates hippocampal neurogenesis and memory deficits in response to Aβ1-42 intracerebroventricular injection in mice 109
In vitro and in vivo analysis of dendritic AMPA receptor mRNAs trafficking 107
In vitro and in vivo analysis of dendritic AMPA receptor mRNAs trafficking 106
3,6'-Dithiothalidomide treatment attenuates neuroinflammation, memory deficits and hippocampal neurogenesis in response to Aβ1-42 intracerebroventricular injection in mice 97
miRNome Profiling Detects miR-101-3p and miR-142-5p as Putative Blood Biomarkers of Frailty Syndrome 97
In vitro and in vivo analysis of dendritic AMPA receptor mRNAs trafficking 96
Impact of COVID-19 on the oncological outcomes of colorectal cancer surgery in northern Italy in 2019 and 2020: multicentre comparative cohort study 95
LRRK2 interacts and phosphorylates Synapsin I: implication for synaptic vesicle trafficking 95
Dopamine-Dependent Ketamine Modulation of Glutamatergic Synaptic Plasticity in the Prelimbic Cortex of Adult Rats Exposed to Acute Stress 93
Genetic and pharmacological evidence that G2019S LRRK2 confers hyperkinetic phenotype and prevents motor decline associated with aging 92
LRRK2 is a positive modulator of neuroinflammation in microglia cells 91
LRRK2 Kinase Inhibition Attenuates Neuroinflammation and Cytotoxicity in Animal Models of Alzheimer's and Parkinson's Disease-Related Neuroinflammation 89
Changes at glutamate tripartite synapses in the prefrontal cortex of a new animal model of resilience/vulnerability to acute stress 88
Leucine-rich repeat kinase-2 controls a-synuclein fibrils clearance in glial cells via clusterin 84
Transcriptional Profiling of Rat Prefrontal Cortex after Acute Inescapable Footshock Stress 84
In vitro Glutamate treatment modify AMPA RNA editing and ADARs activity 83
Functional and Molecular Changes in the Prefrontal Cortex of the Chronic Mild Stress Rat Model of Depression and Modulation by Acute Ketamine 83
LRRK2 kinase activity modulates neuroinflammation in microglia cells 81
LRRK2 positively regulates inflammation and NF-kB p50 inhibitory signaling in microglia cells 79
The protein kinase LRRK2 is involved in neurotransmitter release by interacting and phosphorylating synapsin I in nerve terminals. 76
LRRK2 Kinase Inhibition Attenuates Astrocytic Activation in Response to Amyloid β1-42 Fibrils 75
LRRK2 kinase activity modulates neuroinflammation in microglia cells 74
LRRK2 phosphorylates pre-synaptic N-ethylmaleimide sensitive factor (NSF) enhancing its ATPase activity 74
Impact of Parkinson's disease related LRRK2 protein kinase activity at the pre-synaptic site 69
The group II p21-activated kinases as therapautic targets in LRRK2-related Parkinson’s disease 69
The Down-Regulation of Clusterin Expression Enhances the αSynuclein Aggregation Process 69
ADAR therapeutics to tackle neurodegenerative disorders 67
THE GROUP II P21-ACTIVATED KINASES AS THERAPAUTIC TARGETS IN LRRK2-RELATED PARKINSON'S DISEASE 67
LRRK2 as a target for modulating immune system responses 60
Functional impact of CYFIP2 RNA Editing on actin regulation, axon growth, and spinogenesis 59
Astrocytes carrying LRRK2 G2019S exhibit increased levels of clusterin chaperone via miR-22-5p and reduced ability to take up α-synuclein fibrils 51
ADAR therapeutics to tackle neurodegenerative disorders 49
RNA editing of CYFIP2 regulates in vitro neuronal development 49
Leucine-rich repeat kinase 2-related functions in GLIA: an update of the last years 45
Uncovering the Role of Natural and Synthetic Small Molecules in Counteracting the Burden of α-Synuclein Aggregates and Related Toxicity in Different Models of Parkinson's Disease 39
LRRK2-Mediated Neuroinflammation-Induced Neuronal Dysfunctions in a Parkinson's and Alzheimer's Disease Cellular Model 39
Exploring the effect of LRRK2-mediated neuroinflammation on neuronal tau pathology: implications for Parkinson’s disease 37
Functional impact of CYFIP2 RNA editing on actin regulation, axon growth, and spinogenesis 36
EXPLORING LRRK2-TAU INTERPLAY IN PARKINSON’S DISEASE 34
The Emerging Role of the Molecular Chaperone Clusterin in Parkinson’s Disease 28
Poly-γ-glutamic acid alleviates cytotoxicity and inflammation induced by pre-formed fibrils of α-synuclein in murine primary astrocytes 26
Totale 9.232
Salva come PNG Salva come JPEG
Categoria #
all - tutte 36.882
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 36.882
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202168 0 0 0 0 0 0 0 0 0 0 0 68
2021/2022414 28 71 6 11 3 10 25 30 23 57 42 108
2022/2023392 69 8 15 33 31 95 5 25 70 5 18 18
2023/2024455 21 20 38 73 16 56 15 13 117 4 16 66
2024/20251.013 3 7 20 147 117 106 96 22 58 80 237 120
2025/20262.901 293 355 218 425 315 219 420 130 146 252 89 39
Totale 9.232